Volume : X, Issue : XI, November - 2021
Can low dose subcutaneous tocilizumab substitute standard intravenous tocilizumab for the treatment of cytokine release storm in Covid-19 pneumonia?
Tushar Patel, Kinjal Shah, Ketan Patel, Mukesh Patel, Ambuj Kumar, Atul Patel
Abstract :
Keywords :
Article:
Download PDF
DOI : 10.36106/ijsr
Cite This Article:
CAN LOW DOSE SUBCUTANEOUS TOCILIZUMAB SUBSTITUTE STANDARD INTRAVENOUS TOCILIZUMAB FOR THE TREATMENT OF CYTOKINE RELEASE STORM IN COVID-19 PNEUMONIA?, Tushar Patel, Kinjal Shah, Ketan Patel, Mukesh Patel, Ambuj Kumar, Atul Patel INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH : Volume-10 | Issue-11 | November-2021
Number of Downloads : 189
CAN LOW DOSE SUBCUTANEOUS TOCILIZUMAB SUBSTITUTE STANDARD INTRAVENOUS TOCILIZUMAB FOR THE TREATMENT OF CYTOKINE RELEASE STORM IN COVID-19 PNEUMONIA?, Tushar Patel, Kinjal Shah, Ketan Patel, Mukesh Patel, Ambuj Kumar, Atul Patel INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH : Volume-10 | Issue-11 | November-2021
Our Other Journals...
-
Indian Journal of
Applied Research Visit Website -
PARIPEX Indian Journal
of Research Visit Website -
Global Journal for
Research Analysis Visit Website